RE: Sentiment30 Nov 2021 10:58
Drlong, I agree. In our contempt for the CEO, the ODX Board of Directors and the comm’s, we have lost the point. The stock market works by attempting to value the future potential of a company, what opportunity it represents. I will not bother to list the many ongoing approvals we have in progress and I don’t think any of us, whatever our disappointment at this stage, disbelieve that ODX now have a capacity to produce 100 million tests per annum and few of us doubt that Covid will be around for a while yet and LFT will be required at home and across the world. I still hold to a market price for LFT’s to be around £3.75 and I remain comfortable that our costs to manufacture are no more than £2. Others have suggested that OG sell tests for £2.75 (from memory), quite possibly, it is amazing how paying your employees a few $ a day can help with your overheads. I could argue that HMG would be better paying £3.75 for a UK produced product than importing from China at £2.75 but even if the harsh reality is that ODX had to match this price in the market that would still present a major opportunity. OK my aspirations of £2.50 a share seem long dead, at least whilst I type but 25p really? At £2.75 and producing at full capacity and a p/e of only 3 would comfortably give us £1.24. We are all dissatisfied with the way this company has been managed, this is a separate thing to the company having the opportunity to manufacture 100 million LFT per annum.
I am as financially hurt, angry and contemptuous for the way we appear to have been misled, as anyone. What were they possibly thinking? How could they have acted so badly? Why would they issue so many tweets to confirm our bias that they were busy, negotiating hard on a government contract that would surely slot into place imminently and of course that commercial opportunities in the USA would play a large part in our future? All shocking and we certainly have a right to question their credibility, seek to have them removed and possibly sanctioned but we must not let our justifiable pain blind us to any positives that have managed to hang in there despite everything else.
I do not believe a take over at this stage would be to our advantage we need approvals and orders first to have any chance at receiving fair value. We have cash in the bank to certainly see us through 12 months, probably longer but certainly until we can actually start producing. Investors are hurting but let’s not let our own disappointment and anger blind us to the reality of producing 100m tests per annum - with this board or a new one.